IMPLEMENTASI LISENSI WAJIB TRIPS AGREEMENT DALAM PRODUK FARMASI DI NEGARA KANADA
DOI:
https://doi.org/10.37859/jeq.v8i1.4516
Abstract
Intellectual Property Rights or also known as IPR is a translation of the term Intellectual Property Right (IPR), which means rights born based on someone's intellectual work. Trade Related Aspects of Intellectual Property Rights (hereinafter referred to as the TRIPs Agreement) as the legal basis for IPR in the international scope states. The research methodology uses normative legal research with the data used, namely laws and regulations related to the issues raised as well as some news from print and electronic media from various journals. The results of this study indicate that the country that is most effective in using mandatory licenses in the pharmaceutical sector is Canada. The Canadian Patent Act of 1923 introduced the first mandatory licensing scheme for patented foods and pharmaceutical. In the 1980s, the Government sought to increase pharmaceutical research and development in Canada by increasing protection for patented medicines. Amendments to the Patent Act of 1969 removed restrictions on local manufacturing. Anyone can obtain a compulsory license not only to manufacture but also to import any medicines produced by a patented process. One of the main reasons for the very successful compulsory licensing experience in Canada because of the simple and easy-to-use procedures.
Downloads
References
Buku
Endang Purwaningsih. (2012). Hak Kekayaan Intelektual (HKI) dan Lisensi. Bandung: Mandar Maju,
H.S. Kartadjoemana. (1997). GATT, WTO dan Hasil Uruguay Round. Jakarta : UI Press.
Ishaq. (2017). Metode Penelitian Hukum dan Penulisan Skripsi, Tesis, serta Disertasi. Bandung: Alfabeta.
Peter Mahmud Marzuki. (2013). Penelitian Hukum. Jakarta: Kencana Prenada Media Group.
Soerjono Soekanto & Sri Mamudji. (2001). Penelitian Hukum Normatif Suatu Tinjauan Singkat. Jakarta: PT Raja Grafindo Persada.
Sudaryat, dkk. (2010). Hak Kekayaan Intelektual : Memahami Prinsip Dasar, Cakupan dan Undang-Undang yang Berlaku. Bandung : Oase Media.
Jurnal
Achmad Amri Ichsan. 2014. Analisis Yuridis Terhadap Lisensi Wajib dan Pelaksanaan Paten Oleh Pemerintah Berdasarkan Perjanjian TRIPs. Jurnal Ilmu Hukum Legal Opinion, Vol 2.
Grabowski, Henry. (2018). Patents, Innovations and Access to New Medicines. Journal of International Economic Law, Vol. 5, No. 4, December
Greer, Doglus. (2017). The Case Against Patent System in Less Developed Countries. The Journal of International Law and Economics, Vol. 8, No. 1
Jennifer May Rogers. (2014) The TRIPS Counchil’s Solution To The Paragraf 6 Problem: Towar Compulsory Licensing Viability For Developing Countries. 13 MINN, J. Lobal Trade, 443(4).
Jerome H. Reichman. (2008). Universal Minimum Standards of Intellectual Property Protection, dalam Intellectual Property and International Trade : The TRIPs Agreement, Kluwer Law International BV The Netherland, Zuidpoolsingel.
Luqman Hakim, 2023, Implementasi Lisensi Wajib TRIPs Agreement dalam Produk Farmasi di Negara Swedia, Jurnal Hukum Lex Generalis, Vol 4 No 1
Mansfield, Edwin. (2017). Patents and Innovations: An Empirical Study. Management Science, Vol. 32, No. 2, February.
Puguh Toko Arisanto dan Adi Wibawa, (2019), Implementasi Developmental State India dalam Menghadapi Paten TRIPs dan Strategi Ranbaxy Lab dalam Persaingan Global, Jurnal Transborders, Vol.3, No.1
Putu Ayu Sriasih Wesna. (2020). Doha Declaration sebagai Perlindungan Masyarakat Atas Akses Esensial di Negara Berkembang Pasca Trips Agreement. Jurnal Kertha Wicaksana : Sarana Komunikasi Dosen dan Mahasiswa,Vol.14.
Radhyca Nanda Pratama, Dilla Nurfiana Astanti dan Muh. Ali Masnun, (2019), Implikasi Kewajiban Pelaksanaan Paten terhadap Penyelenggaraan Alih Teknologi, Jurnal Keadilan Fakultas Hukum Universitas Tulang Bawang, Vol.17, No.2
Sri Wartini. The Legal Implication Of Compulsory Licence Pharmaceutical Products In The Trips Agreement To The Protection Of The Right To Health In Developing Countries. Jurnal Dinamika Hukum Vo. 18 No. 1 Januari 2018.
Sumariadi. (2016). Pelaksanaan Compulsory Licensing Paten Obat-Obatan Bidang Farmasi di Indonesia Dikaitkan dengan Doha Declaration On The Trips Agreement And Public Helt. Jurnal De Lega Lata, Vol.1, No.2 .
Tomi Suryo Utomo. Implementasi Lisensi Wajib Terhadap Obat yang Dipatenkan Pasca Deklarasi Doha. Jurnal Ilmu Hukum Refleksi Hukum Edisi April 2009.
Tony Hanoraga & Niken Prasetyawati. 2015. Lisensi Wajib Paten Sebagai Salah Satu Wujud Pembatasan Hak Ekslusif Paten. Jurnal Sosial Humaniora 8(2).
Winner Sitorus. (2014). Kepentingan Umum dalam Perlindungan Paten. Jurnal Yuridika, Vol.29, No.1
Peraturan Perundang-Undangan
World Trade Organization. Pasal 1 ayat 2 Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement).
